These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 21940588)
1. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma. Imsande HM; Davison JM; Truong MT; Devaiah AK; Mercier GA; Ozonoff AJ; Subramaniam RM AJR Am J Roentgenol; 2011 Oct; 197(4):976-80. PubMed ID: 21940588 [TBL] [Abstract][Full Text] [Related]
2. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
3. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108 [TBL] [Abstract][Full Text] [Related]
4. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors. Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948 [TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. Davison JM; Ozonoff A; Imsande HM; Grillone GA; Subramaniam RM Radiology; 2010 May; 255(2):578-85. PubMed ID: 20413767 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma. Abgral R; Le Roux PY; Rousset J; Querellou S; Valette G; Nowak E; Turzo A; Tissot V; Marianowski R; Salaün PY Nucl Med Commun; 2013 Jun; 34(6):551-6. PubMed ID: 23587836 [TBL] [Abstract][Full Text] [Related]
7. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient. Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897 [TBL] [Abstract][Full Text] [Related]
8. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Kidd EA; Siegel BA; Dehdashti F; Grigsby PW Cancer; 2007 Oct; 110(8):1738-44. PubMed ID: 17786947 [TBL] [Abstract][Full Text] [Related]
9. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma. Hofele C; Freier K; Thiele OC; Haberkorn U; Buchmann I Oral Oncol; 2009 Nov; 45(11):963-7. PubMed ID: 19665923 [TBL] [Abstract][Full Text] [Related]
10. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066 [TBL] [Abstract][Full Text] [Related]
11. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
12. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631 [TBL] [Abstract][Full Text] [Related]
13. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas. Lee SW; Nam SY; Im KC; Kim JS; Choi EK; Ahn SD; Park SH; Kim SY; Lee BJ; Kim JH Radiother Oncol; 2008 May; 87(2):211-6. PubMed ID: 18237806 [TBL] [Abstract][Full Text] [Related]
14. Different distribution of (62) Cu ATSM and (18)F-FDG in head and neck cancers. Kositwattanarerk A; Oh M; Kudo T; Kiyono Y; Mori T; Kimura Y; Maruyama R; Fujibayashi Y; Fujieda S; Okazawa H Clin Nucl Med; 2012 Mar; 37(3):252-7. PubMed ID: 22310251 [TBL] [Abstract][Full Text] [Related]
15. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography. Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183 [TBL] [Abstract][Full Text] [Related]
16. Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? Haerle SK; Huber GF; Hany TF; Ahmad N; Schmid DT Eur Arch Otorhinolaryngol; 2010 Oct; 267(10):1635-40. PubMed ID: 20680640 [TBL] [Abstract][Full Text] [Related]
17. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor. Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Machtay M; Natwa M; Andrel J; Hyslop T; Anne PR; Lavarino J; Intenzo CM; Keane W Head Neck; 2009 Feb; 31(2):195-201. PubMed ID: 19107945 [TBL] [Abstract][Full Text] [Related]
19. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096 [TBL] [Abstract][Full Text] [Related]
20. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. Bollineni VR; Widder J; Pruim J; Langendijk JA; Wiegman EM Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e551-5. PubMed ID: 22417800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]